Aktuellt
SENASTE
Redeye endorses CLS entering into a clinical trial agreement with Skåne University Hospital to evaluate MR-guided Laser Interstitial Thermal Therapy (LITT) for glioblastoma ablation. With this agreement in place, CLS is progressing within neurosurgery which we see as a very interesting field for the company over the coming years. We continue to argue that the share is attractive at current share price levels.
LÄS MER
